Edwards Lifesciences (EW) Gains from Investment Securities (2016 - 2025)
Edwards Lifesciences' (EW) quarterly Gains from Investment Securities came in at -$12.5 million in Q3 2025, up 53.53% quarter-over-quarter from -$26.9 million in Q2 2023.
Edwards Lifesciences (EW) Gains from Investment Securities (2016 - 2025) Analysis & Trends
Edwards Lifesciences' Gains from Investment Securities history runs 9 years deep, the most recent figure standing at -$12.5 million for Q3 2025.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$12.5 million in Q3 2025; TTM through Dec 2025 was -$12.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$12.5 million, changed N/A from the prior year.
- Gains from Investment Securities grew to -$12.5 million in Q3 2025 per EW's latest filing, from -$26.9 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.1 million in Q3 2021 and bottomed at -$102.6 million in Q2 2021.
- The 4-year median for Gains from Investment Securities is -$12.5 million (2022), against an average of -$18.1 million.
- Across the five-year window, Gains from Investment Securities tumbled 1236.36% in 2022 and soared 124.14% in 2023, its largest moves.
- Year by year, Gains from Investment Securities stood at -$18.1 million in 2021, then soared by 102.76% to $500000.0 in 2022, then plunged by 5480.0% to -$26.9 million in 2023, then jumped by 53.53% to -$12.5 million in 2025.
- Per Business Quant, the three latest EW Gains from Investment Securities figures stand at -$12.5 million (Q3 2025), -$26.9 million (Q2 2023), and $700000.0 (Q1 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | Steris | 21.45 Bn | 21.01 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -12.50 Mn |
| Sep 30, 2025 | -12.50 Mn |
| Jun 30, 2023 | -26.90 Mn |
| Jun 30, 2023 | -26.90 Mn |
| Mar 31, 2023 | 700,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 500,000.00 |
| Dec 31, 2022 | 500,000.00 |
| Sep 30, 2022 | -12.50 Mn |
| Sep 30, 2022 | -12.50 Mn |
| Jun 30, 2022 | -20.90 Mn |
| Jun 30, 2022 | -20.90 Mn |
| Mar 31, 2022 | -2.90 Mn |
| Mar 31, 2022 | -2.90 Mn |
| Dec 31, 2021 | -18.10 Mn |
| Dec 31, 2021 | -18.10 Mn |
| Sep 30, 2021 | 1.10 Mn |
| Sep 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | -102.60 Mn |
| Jun 30, 2021 | -102.60 Mn |